Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System
Complaint Management

Complaint Management

View Detailed Analysis

Analytics Overview

54
Form 483s Issued
8
483s converted to WL
68
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Nov 2024
Dr. Reddy's Laboratories Limited (Unit II)
Drugs
27 Sep 2024
RC Outsourcing, LLC
Drugs
25 Sep 2024
Nephron Sterile Compounding Center LLC
Drugs
20 Sep 2024
Aarti Drugs Limited
Drugs
28 Aug 2024
Empower Pharmacy
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Pratik S Upadhyay
6
1
Taichun Qin
5
0
Saleem A Akhtar
4
2
Justin A Boyd
4
2
Arsen Karapetyan
4
1
TITLE/ COMPANY Issue Date Status Details
Investigations into product complaints are inadequate to ensure complaint investigations identify appropriate root causes, assess potential product impact, and implement scientific sound sustainable corrective action and preventive action.
Dr. Reddy's Laboratories Limited (Unit II)
19 Nov 2024 Normal Justification: The issue revolves around inadequate complaint management practices, specifically in investigating and resolving customer feedback effectively.
Excerpt: You received a customer complaint #200407887 on 12/20/2022 from US customer for (b) (4) USP (b) (4) which identified the API you supplied (Batch # (b) (4) manufactured on 03/07/2022) showed OOS for Particle Size Distribution...
View Details
Complaint procedures are deficient in that they do not include provisions that allow for the review and determination of an investigation by the quality control unit.
RC Outsourcing, LLC
27 Sep 2024 Normal Justification: The observation directly pertains to Complaint Management as it highlights deficiencies in handling and investigating customer complaints.
Excerpt: Complaint procedures are deficient in that they do not include provisions that allow for the review and determination of an investigation.
View Details
Reserve drug product samples are not appropriately identified and representative of each lot or batch of drug product.
RC Outsourcing, LLC
27 Sep 2024 Normal Justification: Complaints investigation was hindered due to lack of supporting retention samples.
Excerpt: Five complaints of endophthalmitis; no samples available for further examination.
View Details
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch
Nephron Sterile Compounding Center LLC
25 Sep 2024 Normal Justification: Complaints about odors in BFS lots were not properly investigated leading to unresolved customer dissatisfaction.
Excerpt: The complaint vials were thrown away without further investigatory action.
View Details
Written procedures is not established and followed for investigating critical deviations or the failure of a batch
Aarti Drugs Limited
20 Sep 2024 Normal Justification: The occurrence of a market complaint highlights deficiencies in complaint management systems.
Excerpt: you received a market complaint CPL/22005 for the presence of foreign particle.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.